QUOTE AND NEWS
PR Newswire  9 hrs ago  Comment 
In the news release, Perrigo Company to Present at the Credit Suisse 18th Annual Health Care Conference, issued 09-Nov-2009 by Perrigo Company over PR Newswire, we are advised by the company that in the first paragraph, the conference date and time
newratings.com  Nov 3  Comment 
NEW YORK, November 3 (newratings.com) - Analysts at Credit Suisse reiterate their "neutral" rating on Perrigo (ticker: PRGO). The target price has been raised from $37 to $41. [more]
StreetInsider.com  Nov 2  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Perrigo+Co.+%28PRGO%29+Tops+Q1+EPS+Views%2C+Posts+%240.66%3B+Raises+FY10+EPS+Guidance/5062816.html for the full story.
PR Newswire  Nov 2  Comment 
ALLEGAN, Mich., Nov. 2 /PRNewswire-FirstCall/ -- Perrigo Company (Nasdaq: PRGO; TASE) today announced that it has signed a definitive agreement to sell its Israel Consumer Products business along with the related production assets in Israel to Emilia
StreetInsider.com  Oct 29  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Dividends/Perrigo+%28PRGO%29+Decalres+%240.0625+Quarterly+Dividend%3B+0.7%25+Yield/5055233.html for the full story.
MarketWatch  Oct 25  Comment 
Israeli government agencies must approve the major telecom deal.
PR Newswire  Oct 19  Comment 
ALLEGAN, Mich., Oct. 19 /PRNewswire-FirstCall/ -- Perrigo Company (Nasdaq: PRGO; TASE) today announced that it will release financial results for its first quarter fiscal 2010 on Monday, November 2, 2009 at approximately 8:00 a.m. (ET). The Company
StreetInsider.com  Oct 19  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/FDA/Perrigo+%28PRGO%29+Says+Duac+Patent+Litigation+Dismissed/5025497.html for the full story.
Stock Blog Hub  Oct 13  Comment 
Perrigo Company (PRGO) has surprised on estimates the last two quarters as it reported record sales for fiscal 2009. PRGO has a PEG ratio of just 0.94. Company Description Perrigo manufactures over-the-counter and prescription...
Market Intelligence Center  Oct 13  Comment 
Perrigo (NasdaqNM: PRGO) hit a new 52-Week high of $37.11 so far today. Currently the stock is up $0.81 (2.24%) to $37.00 on 1,275,554 shares traded. Today's high is up $18.46 from a 52-Week Low of $18.54. Perrigo stock has been showing support...
Suggest a News Source
Topic
Top news source/blog that we're missing
Why do you recommend this news source?
Close 
Thanks for your suggestion!
 
 
PRGO AT A GLANCE
 
 
 
 
 
 
 
 

Perrigo Company is a global health-care supplier and the world's largest manufacturer of over-the-counter pharmaceuticals for the store brand market. The company develops, distributes, and manufactures over-the-counter and prescription pharmaceuticals, nutritional products, active pharmaceutical ingredients, and consumer products.

Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki